 |
 |
| Taking part in the company's first investor call as a publicly listed firm, Lumenis CEO Tzipi Ozer-Armon was keen to explain the advantages of a new holmium laser system for urology applications. It is undergoing trials in the UK currently. Credit: Lumenis. |
| © 2024 SPIE Europe |
|
